Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

CA 125 Halbwertzeit als neuer Prognosefaktor beim Ovarialkarzinom

  • 34 Accesses

This is a preview of subscription content, log in to check access.

Author information

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Meier, W., Stieber, P., Fateh-Moghadam, A. et al. CA 125 Halbwertzeit als neuer Prognosefaktor beim Ovarialkarzinom. Arch Gynecol Obstet 254, 937–938 (1993). https://doi.org/10.1007/BF02266243

Download citation